Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Citigroup Initiates Coverage of AmerisourceBergen (ABC) with Buy Recommendation
On March 31, 2023, Citigroup initiated coverage of AmerisourceBergen with a Buy recommendation. Analyst Price Forecast Suggests 17.83% Upside As of March 31, 2023, the
Mizuho Initiates Coverage of Vigil Neuroscience (VIGL) with Buy Recommendation
On March 31, 2023, Mizuho initiated coverage of Vigil Neuroscience with a Buy recommendation. Analyst Price Forecast Suggests 109.31% Upside As of March 30, 2023,
CFRA promotes Tesla to Strong Buy ahead of 1Q delivery numbers By Investing.com
CFRA promotes Tesla (TSLA) to Strong Buy ahead of 1Q delivery numbers By Michael Elkins CFRA upgraded Tesla (NASDAQ:) to a Strong Buy rating (from:
Top Stocks To Buy Today? 3 Consumer Staples Stocks To Watch
Consumer staples represent a sector of the economy comprised of companies that produce essential goods and services, such as food and beverages, household products, and
1 Dividend Growth Stock to Buy Hand Over Fist
Dividends are great for passive income or can help boost stock market returns over long periods for those who opt to reinvest them. However, not
1 Magnificent Growth Stock That Can Supercharge Your Portfolio: Time to Buy?
It’s safe to say that Lululemon Athletica (NASDAQ: LULU) is firing on all cylinders right now. In its latest quarter (Q4 2022, ended Jan. 29),
3 Top E-Commerce Stocks to Buy Right Now
E-commerce has hit a rough patch over the last year as a surge in the industry during the early stages of the coronavirus pandemic has
Canaccord Genuity Initiates Coverage of Driven Brands Holdings (DRVN) with Buy Recommendation
On March 30, 2023, Canaccord Genuity initiated coverage of Driven Brands Holdings with a Buy recommendation. Analyst Price Forecast Suggests 32.33% Upside As of March
Canaccord Genuity Initiates Coverage of Lifetime Brands (LCUT) with Buy Recommendation
On March 30, 2023, Canaccord Genuity initiated coverage of Lifetime Brands with a Buy recommendation. Analyst Price Forecast Suggests 111.78% Upside As of March 30,
Stifel Initiates Coverage of Immunovant (IMVT) with Buy Recommendation
On March 30, 2023, Stifel initiated coverage of Immunovant with a Buy recommendation. Analyst Price Forecast Suggests 56.92% Upside As of March 30, 2023, the